Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: RVTY )

113.27 +1.38 (+1.23%)
Official Closing Price Updated: 7:00 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 647,663
Open 112.15
Bid (Size) 89.71 (1)
Ask (Size) 135.69 (1)
Prev. Close 111.89
Today's Range 111.75 - 113.46
52wk Range 79.50 - 131.96
Shares Outstanding N/A
Dividend Yield 0.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
4 Analysts Have This To Say About Revvity
Via Benzinga
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc.... 
Via Benzinga

Performance

YTD
+2.57%
+2.57%
1 Month
+10.31%
+10.31%
3 Month
+8.45%
+8.45%
6 Month
+25.73%
+25.73%
1 Year
-3.74%
-3.74%

More News

Read More
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Revvity Announces Financial Results for the First Quarter of 2024
From Revvity
Via Business Wire
Earnings Preview For Revvity
Via Benzinga
The Latest Analyst Ratings For Revvity
Via Benzinga
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Revvity to Present at BofA Securities 2024 Health Care Conference
From Revvity
Via Business Wire
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Revvity Unveils a New Era of Automated Tuberculosis Testing
From Revvity
Via Business Wire
Peeling Back The Layers: Exploring Revvity Through Analyst Insights
Via Benzinga
7 Analysts Have This to Say About Revvity
Via Benzinga
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
From Revvity
Via Business Wire
Revvity To Hold Earnings Call on Monday, April 29, 2024
From Revvity
Via Business Wire
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
From Revvity
Via Business Wire
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
From Revvity
Via Business Wire
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
From Revvity
Via Business Wire
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
From Revvity
Via Business Wire
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
From Revvity
Via Business Wire
Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
From Revvity
Via Business Wire
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance
From Revvity
Via Business Wire
Earnings Scheduled For February 1, 2024
Via Benzinga
Revvity to Present at J.P. Morgan Healthcare Conference
From Revvity
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.